Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Ascendis Pharma ( (ASND) ).
On April 8, 2026, Ascendis Pharma announced it will transition from trading American Depositary Shares to a direct listing of its ordinary shares on The Nasdaq Global Select Market. The company expects the change to become effective at the opening of trading on April 20, 2026, with ASND remaining its Nasdaq ticker symbol.
As part of the move, all outstanding ADSs will be mandatorily exchanged on a one-for-one basis into ordinary shares, with the last day of ADS trading on Nasdaq anticipated to be April 17, 2026. The shift is designed to simplify the capital structure for investors, although the company has cautioned that execution risks, potential tax consequences, and possible changes in trading liquidity or dynamics could affect ADS holders and other security holders during the transition.
The most recent analyst rating on (ASND) stock is a Buy with a $342.00 price target. To see the full list of analyst forecasts on Ascendis Pharma stock, see the ASND Stock Forecast page.
Spark’s Take on ASND Stock
According to Spark, TipRanks’ AI Analyst, ASND is a Neutral.
The score is driven primarily by improving fundamentals (rapid revenue growth, strong margins, and a move to positive operating/free cash flow) but is held back by balance-sheet risk (negative equity and high debt) and unprofitable earnings (negative P/E). Technicals are neutral-to-slightly cautious, while the latest earnings call adds support via upbeat guidance and commercial/pipeline momentum despite elevated operating expenses and near-term volatility risks.
To see Spark’s full report on ASND stock, click here.
More about Ascendis Pharma
Ascendis Pharma A/S is a Denmark-based biopharmaceutical company whose ordinary shares and related securities trade on U.S. capital markets. The company is listed on The Nasdaq Global Select Market under the ticker symbol ASND, giving it access to a broad base of international healthcare and growth-oriented investors.
Average Trading Volume: 680,775
Technical Sentiment Signal: Buy
Current Market Cap: $13.53B
See more data about ASND stock on TipRanks’ Stock Analysis page.